Psichedelia (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Psichedelia" in Italian language version.

refsWebsite

Global rank Italian rank

6doi.org

2^nd place

7^th place

1drugabuse.gov

6,166^th place

low place

1maps.org

low place

7,505^th place

1minimaetmoralia.it

low place

4,078^th place

1scaruffi.com

7,665^th place

313^th place

1worldcat.org

5^th place

26^th place

1nature.com

234^th place

226^th place

1newsweek.com

269^th place

570^th place

1michaelpollan.com

low place

1washingtonian.com

4,461^st place

low place

1rivistastudio.com

low place

1,121^st place

doi.org

dx.doi.org

(EN) Robin L Carhart-Harris, Leor Roseman e Mark Bolstridge, Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms, in Scientific Reports, vol. 7, n. 1, 13 ottobre 2017, DOI:10.1038/s41598-017-13282-7. URL consultato il 23 settembre 2018.
Franz X. Vollenweider e Michael Kometer, The neurobiology of psychedelic drugs: implications for the treatment of mood disorders, in Nature Reviews Neuroscience, vol. 11, n. 9, 18 agosto 2010, pp. 642-651, DOI:10.1038/nrn2884. URL consultato il 10 novembre 2018.
Peter Gasser, Dominique Holstein e Yvonne Michel, Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases, in The Journal of Nervous and Mental Disease, vol. 202, n. 7, 2014-07, pp. 513-520, DOI:10.1097/nmd.0000000000000113. URL consultato il 10 novembre 2018.
Charles S. Grob, Alicia L. Danforth e Gurpreet S. Chopra, Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer, in Archives of General Psychiatry, vol. 68, n. 1, 3 gennaio 2011, p. 71, DOI:10.1001/archgenpsychiatry.2010.116. URL consultato il 10 novembre 2018.
Michael C Mithoefer, Ann T Mithoefer e Allison A Feduccia, 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial, in The Lancet Psychiatry, vol. 5, n. 6, 2018-06, pp. 486-497, DOI:10.1016/s2215-0366(18)30135-4. URL consultato il 10 novembre 2018.
Michael C Mithoefer, Charles S Grob e Timothy D Brewerton, Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA, in The Lancet Psychiatry, vol. 3, n. 5, 2016-05, pp. 481-488, DOI:10.1016/s2215-0366(15)00576-3. URL consultato il 10 novembre 2018.

drugabuse.gov

archives.drugabuse.gov

(EN) National Institute on Drug Abuse, Classical drugs: an introductory overview. Hallucinogens: an update (PDF), in Geraldine C. Lin e Richard A. Glennon (a cura di), NIDA Research Monograph Series, n. 146, Rockville, Maryland, U.S. Department of Health and Human Services - National Institute on Drug Abuse, 1994. URL consultato il 5 settembre 2020.